Raymond James Financial Services Advisors, Inc. 10x Genomics, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 28,844 shares of TXG stock, worth $446,505. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,844Holding current value
$446,505% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
291Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$170 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$166 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$100 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$99 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$98.7 Million1.67% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.47B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...